Travaux scientifiques

Doç. Dr. Doğan Yazılıtaş

101 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil

  1. ACCESSORY SPLEEN HYPERTROPHY MIMICKING COLON CANCER METASTASIS

    Experimental Oncology, 2016

    DOI 10.31768/2312-8852.2016.38(3):202-203 PMID 27685531 3 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  2. Evaluation of prognostic factors in localized high-grade undifferentiated pleomorphic sarcoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology

    Tumor Biology, 2015

    DOI 10.1007/s13277-015-4359-1 PMID 26553363 13 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  3. Mide Kanserinde Tanı Anındaki Evre ile Patolojik Alt Tip ve Lokalizasyonun İlişkisi

    2015

    Source : OpenAlex

  4. Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumab.

    Breast (Edinburgh, Scotland), 2015

    DOI 10.1016/j.breast.2015.11.006 PMID 26801412 23 citations (Europe PMC) Source : ORCID

  5. Treatment approaches in 102 elderly patients with non-small cell lung cancer

    CJAM Canadian Journal of Addiction Medicine, 2015

    DOI 10.14740/wjon894w PMID 29147416 Texte intégral en libre accèsSource : ORCID

  6. 3238 The effect of “international prognostic index (IPI)” in the determination of prognosis of early stage diffuse large b cell non-hodgkin lymphoma: Is it enough?

    European Journal of Cancer, 2015

    DOI 10.1016/s0959-8049(16)31815-9 Source : OpenAlex

  7. 2395 The importance of thiol/disulphide homeostasis in patients with advanced gastric cancer (AGC) receiving modified docetaxel and cisplatin plus fiuorouracil (mDCF) regimen

    European Journal of Cancer, 2015

    DOI 10.1016/s0959-8049(16)31311-9 Source : OpenAlex

  8. doctor

    2015

    Source : ORCID

  9. A retrospective comparison of early stage primary extranodal with nodal non-Hodgkin lymphoma patients: A single center experience

    Journal of B.U.ON., 2015

    PMID 26854450 3 citations (OpenAlex) Source : ORCID

  10. Adult Urological Soft Tissue Sarcomas: A Multicenter Study of the Anatolian Society of Medical Oncology (ASMO)

    Asian Pacific Journal of Cancer Prevention, 2015

    DOI 10.7314/apjcp.2015.16.11.4777 PMID 26107239 Texte intégral en libre accèsSource : ORCID

  11. Concordance of positron emission tomography and computed tomography in patients with locally advanced gastric and esophageal cancer

    Annals of Nuclear Medicine, 2015

    DOI 10.1007/s12149-015-0985-3 PMID 26008856 6 citations (Europe PMC) Source : ORCID

  12. Efficacy of Dose Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel versus Conventional Dose Doxorubicin, Cyclophosphamide Followed by Paclitaxel or Docetaxel in Patients with Node-Positive Breast Cancer

    Asian Pacific Journal of Cancer Prevention, 2015

    DOI 10.7314/apjcp.2015.16.4.1471 PMID 25743817 2 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  13. Is second-line systemic chemotherapy beneficial in patients with non-small cell lung cancer (NSCLC)? A multicenter data evaluation by the Anatolian Society of Medical Oncology

    Tumor Biology, 2015

    DOI 10.1007/s13277-015-3728-0 PMID 26150339 5 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  14. Rectal Cancer With Metastasis to the Face

    UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi, 2015

    DOI 10.4999/uhod.15903 2 citations (OpenAlex) Texte intégral en libre accèsSource : ORCID

  15. Adjuvant Therapy in Patients with Gallbladder Carcinoma

    Journal of Gastroenterology and Hepatology Research, 2015

    DOI 10.17554/j.issn.2224-3992.2015.04.484 Texte intégral en libre accèsSource : OpenAlex

  16. 2350 The efficacy and predictive factors of response of second line triplet (modified-EOX; epirubicin-oxaliplatin-capacitabine) regimen in metastatic gastric cancer

    European Journal of Cancer, 2015

    DOI 10.1016/s0959-8049(16)31266-7 Source : OpenAlex

  17. 3223 The comparison of early stage primary nodal and extranodal diffuse large cell lymphomas: Clinical features, treatment and survival outcomes

    European Journal of Cancer, 2015

    DOI 10.1016/s0959-8049(16)31800-7 Source : OpenAlex

  18. Factors of early recurrence (

    Journal of Clinical Oncology, 2015

    DOI 10.1200/jco.2015.33.15_suppl.e12066 Source : OpenAlex

  19. Breast cancer subtypes and the risk of distant relapse after breast conserving surgery or mastectomy: An Anatolian Society of Medical Oncology study.

    Journal of Clinical Oncology, 2015

    DOI 10.1200/jco.2015.33.15_suppl.e12052 Texte intégral en libre accèsSource : OpenAlex

  20. Breast cancer subtypes and the risk of distant relapse after breast conserving surgery or mastectomy: An Anatolian Society of Medical Oncology study.

    Bursa Uludag University - AVESIS, 2015

    Source : OpenAlex

  21. THE EFFECT OF INTERNATIONAL PROGNOSTIC INDEX IPI IN THEDETERMINATION OF PROGNOSIS OF EARLY STAGE DIFFUSE LARGE B CELLNON HODGKIN LYMPHOMA IS IT ENOUGH

    AYBU AVESIS, 2015

    Source : OpenAlex

  22. Factors of early recurrence ( 24 months) in relapsed node negative early stage breast cancer (the study of Anatolian Society of Medical Oncology).

    Bursa Uludag University - AVESIS, 2015

    Source : OpenAlex

  23. The ef cacy and predictive factors of response of second line triplet modi ed EOX epirubicin oxaliplatin capacitabine regimen in metastatic gastric cancer

    AYBU AVESIS, 2015

    Source : OpenAlex

  24. The effect of body mass index in patients with relapsed colorectal cancer

    AYBU AVESIS, 2015

    Source : OpenAlex

  25. The importance of thiol disulphide homeostasis in patients with advanced gastric cancer AGC receiving modi ed docetaxel and cisplatin plus uorouracil mDCF regimen

    AYBU AVESIS, 2015

    Source : OpenAlex

  26. Assessment of tumor characteristics and factors affecting survival in patients with primary metastatic breast carcinoma: A Multicenter Study of the Anatolian Society of Medical Oncology

    Medical Oncology, 2014

    DOI 10.1007/s12032-014-0929-0 PMID 24659267 4 citations (Europe PMC) Source : ORCID

  27. Recurrence risk and prognostic parameters in stage I rectal cancers

    Asian Pacific Journal of Cancer Prevention, 2014

    DOI 10.7314/apjcp.2014.15.13.5337 PMID 25040998 1 citation (Europe PMC) Texte intégral en libre accèsSource : ORCID

  28. Morphine: Patient Knowledge and Attitudes in the Central Anatolia Part of Turkey

    Asian Pacific Journal of Cancer Prevention, 2014

    DOI 10.7314/apjcp.2014.15.12.4983 PMID 24998575 13 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  29. Comparison the efficacy of second-line modified EOX (epirubicin, oxaliplatin, and capecitabine) and irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) regimens in metastatic gastric cancer patients that progressed on first-line modified docetaxel and cisplatin plus fluorouracil (DCF) regimen

    Medical Oncology, 2014

    DOI 10.1007/s12032-014-0153-y PMID 25099765 1 citation (Europe PMC) Source : ORCID

  30. EFFICACY OF ADJUVANT 9-WEEKS TRASTUZUMAB IN NODE-NEGATIVE T1A/B HER2-POSITIVE BREAST CANCER

    Annals of Oncology, 2014

    DOI 10.1093/annonc/mdu327.44 Texte intégral en libre accèsSource : ORCID

  31. Efficacy and Safety of First Line Vincristine with Doxorubicin, Bleomycin and Dacarbazine (ABOD) for Hodgkin's Lymphoma: a Single Institute Experience

    Asian Pacific Journal of Cancer Prevention, 2014

    DOI 10.7314/apjcp.2014.15.20.8715 PMID 25374196 4 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  32. XELOX Plus Bevacizumab vs. FOLFIRI Plus Bevacizumab Treatment for First-line Chemotherapy in Metastatic Colon Cancer: a Retrospective Study of the Anatolian Society of Medical Oncology

    Asian Pacific Journal of Cancer Prevention, 2014

    DOI 10.7314/apjcp.2014.15.23.10375 PMID 25556478 4 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  33. Nadir Görülen Sarkom Türleri

    Turkiye Klinikleri Medical Oncology - Special Topics, 2014

    Source : OpenAlex

  34. Metastatik safra kesesi kanserinde kemoterapinin yeri: Retrospektif değerlendirme

    Cumhuriyet Tıp Dergisi/Cumhuriyet Üniversitesi Tıp Fakültesi dergisi, 2014

    DOI 10.7197/cmj.v36i4.5000071499 Texte intégral en libre accèsSource : OpenAlex

  35. Comparison the Efficacy of Second Line Eox and Folfiri Regimens in Metastatic Gastric Cancer

    Annals of Oncology, 2014

    DOI 10.1093/annonc/mdu334.66 Texte intégral en libre accèsSource : OpenAlex

  36. Retrospective evaluation of premenopausal hormone-sensitive breast cancer patients treated with adjuvant gonadotropin-releasing hormone analogue.

    Journal of Clinical Oncology, 2014

    DOI 10.1200/jco.2014.32.15_suppl.e11542 Texte intégral en libre accèsSource : OpenAlex

  37. Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience

    Oncology Letters, 2013

    DOI 10.3892/ol.2013.1408 PMID 24137379 11 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  38. Prognostic Factors for Recurrence-Free Survival in Patients with HER2-Positive Early-Stage Breast Cancer Treated with Adjuvant Trastuzumab

    Karger Kompass Onkologi, 2013

    DOI 10.1159/000355156 PMID 24107908 3 citations (Europe PMC) Source : ORCID

  39. Biologic subtypes and first relapse pattern in curative surgery performed breast cancer patients: Study of Anatolian Society of Medical Oncology.

    Journal of Clinical Oncology, 2013

    DOI 10.1200/jco.2013.31.15_suppl.e11559 1 citation (OpenAlex) Source : OpenAlex

  40. PharmaForum

    Onkologie, 2013

    DOI 10.1159/000178571 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  41. Retrospective analysis of 178 patients with stage I rectum cancer.

    Journal of Clinical Oncology, 2013

    DOI 10.1200/jco.2013.31.15_suppl.e14662 Texte intégral en libre accèsSource : OpenAlex

  42. PharmaForum

    Onkologie, 2013

    DOI 10.1159/000178570 Texte intégral en libre accèsSource : OpenAlex

  43. PharmaForum

    Onkologie, 2013

    DOI 10.1159/000178568 Source : OpenAlex

  44. PharmaNews

    Onkologie, 2013

    DOI 10.1159/000178589 Texte intégral en libre accèsSource : OpenAlex

  45. PharmaForum

    Onkologie, 2013

    DOI 10.1159/000178587 Texte intégral en libre accèsSource : OpenAlex

  46. Imprint

    Onkologie, 2013

    DOI 10.1159/000178608 Source : OpenAlex

  47. Meetings and Conferences · Tagungen und Kongresse

    Onkologie, 2013

    DOI 10.1159/000178596 Texte intégral en libre accèsSource : OpenAlex

  48. Mitteilungen onkologischer Gesellschaften · Reports of Oncological Societies

    Onkologie, 2013

    DOI 10.1159/000178597 Texte intégral en libre accèsSource : OpenAlex

  49. PharmaNews

    Onkologie, 2013

    DOI 10.1159/000178588 Source : OpenAlex

  50. Biologic subtypes and first relapse pattern in curative surgery performed breast cancer patients: Study of Anatolian Society of Medical Oncology.

    Bursa Uludag University - AVESIS, 2013

    Source : OpenAlex